Therapeutics: Ribosomal protein S6 kinase 70kDa polypeptide 1 (RPS6KB1; S6K1); mammalian target of rapamycin (mTOR; FRAP; RAFT1)

Cancer

INDICATION: Cancer

Cell culture and mouse studies suggest combining inhibitors of glycolysis and the mTOR/RPS6KB1 pathway could help treat cancer. In a human ovarian

Read the full 239 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE